Filling the need for trusted information on national health issues…

Trending on kff Open Enrollment Medicare Part D Medicaid Expansion

  • your selections
Clear Search

Filter Results

date

Topics

Tags

Type

  • results
What New Data Tell Us About Doctor Choice

Drew Altman explores the rhetoric versus reality on whether choice of doctors is eroding and why the issue resonates with Americans, in this column for The Wall Street Journal’s Think Tank.

JAMA Forum: Surprise, Surprise

Larry Levitt’s February 2016 post explains how “surprise medical bills” — unanticipated charges for out-of-network care – can happen. It describes some government approaches to the issue and outlines the challenges to protecting consumers. The post is now available at The JAMA Forum.

Zika Virus: The Challenge for Women

In the latest post in the Policy Insights series, Jen Kates, Josh Michaud, and Allison Valentine examine how rapid emergence of Zika virus in the Americas, and its association with a severe birth defect, impact women as some health officials are calling for women to avoid pregnancy even though they have limited reproductive health access in some of the affected countries. They also examine the role of the U.S. government in addressing Zika and its impact on women in Latin America and the Caribbean.

Reading the Tea Leaves on U.S. Global Health Policy

In this Policy Insight, Jen Kates and Josh Michaud look at the prospects for the future of U.S. global health policy, examining whether long-term bipartisan support may be tested during a time of political transition, and identifying key areas of consensus among policymakers and the public.

How Health-Care Bills Hinder Millions of Americans

In this column for The Wall Street Journal’s Think Tank, Drew Altman examines the problems many Americans with health insurance are having paying medical bills based on a new Kaiser-New York Times Survey, and discusses why the issue of the adequacy of insurance coverage is gaining traction.

How High Drug Prices Weigh on the Sickest Americans

In this column for The Wall Street Journal’s Think Tank, Drew Altman explores the data behind public concern about prescription drug costs and highlights that the people most in need are the most burdened by the problem.

Bernie Sanders, Hillary Clinton, and Medicare for All

In this column for The Wall Street Journal’s Think Tank, Drew Altman explores the differing positions of presidential candidates Hillary Clinton and Bernie Sanders on a single payer or Medicare-for-all health care system and whether Democratic voters consider it an important factor in the 2016 primaries.

Prescription Drugs’ Sizable Share of Health Spending

In this column for The Wall Street Journal’s Think Tank, Drew Altman explains why prescription drug spending may be a larger share of health spending than most people think, depending on how you look at it.